Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of Mexico

Table 5

The recurrence prognostic value of the tumor characteristics.

Tumor characteristics	Recurrence group	Control group	𝑃 value
Advanced clinical stage	52 (86.6%)	50 (83.3%)	0.609
Tumor size > 5 cm	36 (60%)	44 (73.3%)	0.121
Histological grade SBR 2; 3	50 (98%)	46 (95.8%)	0.610
Lymph vascular invasion	26 (43.3%)	13 (21.6%)	0.011
Positive estrogen receptor status	24 (40%)	25 (41.66%)	0.714
Positive progesterone receptor status	19 (31.66%)	24 (40.01%)	0.854
Positive ER PR status	29 (54.7%)	31 (59.6%)	0.572
Pathological lymph nodes status (positive versus negative)	44 (73.3%)	23 (38.3%)	<0.0001
Her2/neu expression	6 (19.19%)	10 (23.81%)	0.382
Pathological complete response	19 (31.67%)	8 (13.33%)	0.034